Osiris Therapeutics Inc. (NASDAQ:OSIR) shares traded up 6.6% on Friday . The company traded as high as $5.82 and last traded at $5.67, with a volume of 61,705 shares changing hands. The stock had previously closed at $5.32.

Separately, Zacks Investment Research lowered shares of Osiris Therapeutics from a “hold” rating to a “sell” rating in a research note on Monday, April 11th.

The stock has a market cap of $190.52 million and a P/E ratio of 131.67. The firm’s 50-day moving average price is $5.09 and its 200-day moving average price is $5.74.

An institutional investor recently raised its position in Osiris Therapeutics stock. GSA Capital Partners LLP boosted its stake in Osiris Therapeutics Inc. (NASDAQ:OSIR) by 10.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 98,901 shares of the company’s stock after buying an additional 9,702 shares during the period. GSA Capital Partners LLP owned about 0.29% of Osiris Therapeutics worth $1,027,000 at the end of the most recent reporting period.

Osiris Therapeutics, Inc is a medical products company. The Company is focused on developing and marketing products in regenerative medicine, including bioengineering, stem cell research and viable tissue based products. The Company’s offers products in orthopedics, sports medicine and wound care, including Cartiform, BIO4 and Grafix.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.